Abalone Bio develops pharmacologically antibody drugs to successfully treat metaolic and inflammatory diseases where other drugs fail
Abalone Bio's investors include Y Combinator, National Science Foundation.
Abalone Bio is headquartered in Emeryville, United States.
Abalone Bio develops pharmacologically antibody drugs to successfully treat metaolic and inflammatory diseases where other drugs fail
Abalone Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abalone Bio — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/abalone-bio. Accessed September 30, 2026.
VCBacked. (2024). Abalone Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/abalone-bio
{{cite web |title=Abalone Bio — Funding & Investors |url=https://www.vcbacked.co/company/abalone-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated